Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 18;7(4):357-363.
doi: 10.1515/dx-2020-0078.

COVID-19-associated coagulopathy

Massimo Franchini  1   2 , Giuseppe Marano  1 , Mario Cruciani  1   3 , Carlo Mengoli  1 , Ilaria Pati  1 , Francesca Masiello  1 , Eva Veropalumbo  1 , Simonetta Pupella  1 , Stefania Vaglio  1 , Giancarlo Maria Liumbruno  1
Affiliations
Free article
Review

COVID-19-associated coagulopathy

Massimo Franchini et al. Diagnosis (Berl). .
Free article

Abstract

Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized as a systemic disorder inducing a prothrombotic state. The molecular mechanisms underlying the hypercoagulable state seen in patients with COVID-19 is still incompletely understood, although it presumably involves the close link between inflammatory and hemostatic systems. The laboratory coagulation monitoring of severely ill COVID-19 patients is mandatory to identify those patients at increased thrombotic risk and to modulate thromboprophylaxis accordingly. In this review, we summarize the current understanding on the pathogenesis, epidemiology, clinical and laboratory features and management of coagulopathy associated with COVID-19.

Keywords: COVID-19; SARS-CoV-2; anticoagulant therapy; prophylaxis; thromboembolism; thrombosis.

PubMed Disclaimer

References

    1. Zhai, P, Ding, Y, Wu, X, Long, J, Zhong, Y, Li, Y. The epidemiology, diagnosis, and treatment of COVID-19. Int J Antimicrob Agents 2020;55:105955. https://doi.org/10.1016/j.ijantimicag.2020.105955.
    1. Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3.
    1. Peeri, NC, Shrestha, N, Rahman, MS, Zaki, R, Tan, Z, Bibi, S, et al. The SARS, MERS, and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 2020 Feb 22. https://doi.org/10.1093/ije/dyaa033 [Epub ahead of print].
    1. Xie, M, Chen, Q. Insight into 2019 novel coronavirus – an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 2020 Apr 1. https://doi.org/10.1016/j.ijid.2020.03.071 [Epub ahead of print].
    1. Holshue, ML, DeBolt, C, Lindquist, S, Lofy, KH, Wiesman, J, Bruce, H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929–36. https://doi.org/10.1056/nejmoa2001191.

MeSH terms

LinkOut - more resources